450 related articles for article (PubMed ID: 21865693)
1. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
[TBL] [Abstract][Full Text] [Related]
2. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
Horie A; Hiki Y; Odani H; Yasuda Y; Takahashi M; Kato M; Iwase H; Kobayashi Y; Nakashima I; Maeda K
Am J Kidney Dis; 2003 Sep; 42(3):486-96. PubMed ID: 12955676
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
Hiki Y; Horie A; Yasuda Y; Iwase H; Sugiyama S
Acta Otolaryngol Suppl; 2004 Dec; (555):28-31. PubMed ID: 15768794
[TBL] [Abstract][Full Text] [Related]
4. Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum.
Iwanami N; Iwase H; Takahashi N; Kato K; Itoh A; Takatani T; Makita S; Kobayashi Y; Okamoto M; Nakamura S; Hiki Y; Ishii M
J Nephrol; 2008; 21(1):118-26. PubMed ID: 18264945
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
[TBL] [Abstract][Full Text] [Related]
6. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of IgA nephropathy.
Feehally J; Allen AC
Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
[TBL] [Abstract][Full Text] [Related]
8. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
9. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
11. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
12. The role of tonsillectomy in IgA nephropathy.
Feriozzi S; Polci R
J Nephrol; 2016 Feb; 29(1):13-9. PubMed ID: 26582216
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy.
Xie Y; Chen X; Nishi S; Narita I; Gejyo F
Kidney Int; 2004 Apr; 65(4):1135-44. PubMed ID: 15086452
[TBL] [Abstract][Full Text] [Related]
14. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
Allen AC
J Nephrol; 1999; 12(2):76-84. PubMed ID: 10378662
[TBL] [Abstract][Full Text] [Related]
15. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Oba K; Hiki Y; Kobayashi Y; Okamoto M
Nephrol Dial Transplant; 2003 Jun; 18(6):1108-14. PubMed ID: 12748342
[TBL] [Abstract][Full Text] [Related]
16. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
17. O-glycosylation of serum IgD in IgA nephropathy.
Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
[TBL] [Abstract][Full Text] [Related]
18. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.
Iwatani H; Inoue T; Wada Y; Nagasawa Y; Yamamoto R; Iijima H; Takehara T; Imai E; Rakugi H; Isaka Y
Biochem Biophys Res Commun; 2012 Nov; 428(3):339-42. PubMed ID: 23098908
[TBL] [Abstract][Full Text] [Related]
19. Structural features of IgA molecules which contribute to IgA nephropathy.
Feehally J; Allen AC
J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy.
Inoue T; Sugiyama H; Hiki Y; Takiue K; Morinaga H; Kitagawa M; Maeshima Y; Fukushima K; Nishizaki K; Akagi H; Narimatsu Y; Narimatsu H; Makino H
Clin Immunol; 2010 Sep; 136(3):447-55. PubMed ID: 20538527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
